After @ months , the primary outcome of mean spine bone mineral density increased by @ % ( @ % CI @-@ ) in @ women in the teriparatide to denosumab group , @ % ( @-@ ) in @ women the denosumab to teriparatide group , and @ % ( @-@ ) in @ women in the combination to denosumab group , although this increase did not differ significantly between groups ( for between-group comparisons , p = @ for the teriparatide to denosumab group vs the denosumab to teriparatide group , p = @ for the teriparatide to denosumab group vs the combination to denosumab group , and p = @ for the denosumab to teriparatide group vs the combination to denosumab group ) .